Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3262398092;98093;98094 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
N2AB3098293169;93170;93171 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
N2A3005590388;90389;90390 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
N2B2355870897;70898;70899 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
Novex-12368371272;71273;71274 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
Novex-22375071473;71474;71475 chr2:178540299;178540298;178540297chr2:179405026;179405025;179405024
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Fn3-126
  • Domain position: 24
  • Structural Position: 26
  • Q(SASA): 0.5055
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/A rs1171694976 -1.291 0.081 N 0.354 0.139 0.423716096872 gnomAD-2.1.1 4.02E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
V/A rs1171694976 -1.291 0.081 N 0.354 0.139 0.423716096872 gnomAD-4.0.0 1.5913E-06 None None None None N None 0 2.28634E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.0973 likely_benign 0.0938 benign -1.761 Destabilizing 0.081 N 0.354 neutral N 0.341835323 None None N
V/C 0.4975 ambiguous 0.4675 ambiguous -1.392 Destabilizing 0.958 D 0.591 neutral None None None None N
V/D 0.2503 likely_benign 0.2588 benign -1.711 Destabilizing 0.301 N 0.583 neutral N 0.454411467 None None N
V/E 0.1883 likely_benign 0.1911 benign -1.627 Destabilizing 0.22 N 0.533 neutral None None None None N
V/F 0.1653 likely_benign 0.1664 benign -1.153 Destabilizing 0.427 N 0.625 neutral N 0.484561016 None None N
V/G 0.1926 likely_benign 0.1821 benign -2.164 Highly Destabilizing 0.175 N 0.54 neutral N 0.41662387 None None N
V/H 0.3882 ambiguous 0.3591 ambiguous -1.566 Destabilizing 0.958 D 0.574 neutral None None None None N
V/I 0.0734 likely_benign 0.0718 benign -0.718 Destabilizing 0.001 N 0.165 neutral N 0.483520866 None None N
V/K 0.243 likely_benign 0.2513 benign -1.658 Destabilizing 0.22 N 0.545 neutral None None None None N
V/L 0.1173 likely_benign 0.1131 benign -0.718 Destabilizing 0.007 N 0.349 neutral N 0.458739852 None None N
V/M 0.1184 likely_benign 0.1168 benign -0.673 Destabilizing 0.497 N 0.551 neutral None None None None N
V/N 0.2017 likely_benign 0.1905 benign -1.637 Destabilizing 0.667 D 0.622 neutral None None None None N
V/P 0.1291 likely_benign 0.1176 benign -1.032 Destabilizing None N 0.399 neutral None None None None N
V/Q 0.2052 likely_benign 0.1928 benign -1.684 Destabilizing 0.667 D 0.625 neutral None None None None N
V/R 0.2291 likely_benign 0.2376 benign -1.169 Destabilizing 0.667 D 0.62 neutral None None None None N
V/S 0.1313 likely_benign 0.1212 benign -2.221 Highly Destabilizing 0.22 N 0.527 neutral None None None None N
V/T 0.134 likely_benign 0.1253 benign -2.005 Highly Destabilizing 0.104 N 0.429 neutral None None None None N
V/W 0.6803 likely_pathogenic 0.6673 pathogenic -1.394 Destabilizing 0.958 D 0.619 neutral None None None None N
V/Y 0.4097 ambiguous 0.3914 ambiguous -1.101 Destabilizing 0.667 D 0.619 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.